2021-2022 NAVY INFLUENZA VACCINATION AND REPORTING POLICY:
R 221850Z OCT 21 MID600051074031U
FM CNO WASHINGTON DC
INFO CNO WASHINGTON DC
PASS TO OFFICE CODES:
INFO CNO WASHINGTON DC//DNS//
MSGID/GENADMIN/CNO WASHINGTON DC//
SUBJ/2021-2022 NAVY INFLUENZA VACCINATION AND REPORTING POLICY//
REF/C/DOC/32 CFR PART 199.21/1DEC2016//
REF/E/MORBIDITY AND MORTALITY WEEKLY REPORT (MMWR)
NARR/REF A IS THE DODI 6025.19 INDIVIDUAL MEDICAL READINESS.
REF B IS THE DEFENSE HEALTH AGENCY PROCEDURAL INSTRUCTION 6025.34 GUIDANCE
FOR THE DOD INFLUENZA VACCINATION PROGRAM (IVP).
REF C IS 32 CFR PART 199.21, CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE
UNIFORMED SERVICES (CHAMPUS)/TRICARE: TRICARE PHARMACY BENEFITS PROGRAM.
REF D IS DOD INSTRUCTION ADRESSING IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE
PREVENTION OF INFECTIOUS DISEASES.
REF E IS A WEEKLY MMWR REPORT PROVIDED BY THE CENTERS FOR DISEASE CONTROL AND
REF F IS THE DHA IPM 20-004 DEPARTMENT OF DEFENSE CORONAVIIRUS DISEASE 2019
VACCINATION PROGRAM IMPLEMENTATION.//
POC/CDR PETER SEGUIN/FALLS CHURCH VA/ (703) 681-9474/
RMKS/1. Influenza is a contagious viral respiratory illness, which can cause
mild to severe illness resulting in hospitalization or death.
Influenza has the potential to adversely impact Navy force readiness and
2. Influenza Vaccination and Reporting
a. Influenza Disease Prevention. Vaccination is the primary method to
reduce risk of influenza by enhancing force immunity. Maintaining a clean
work environment, good hygiene practices including cough/sneeze hygiene, and
managing workforce exposure (e.g., social distancing, teleworking, and sick
leave) are effective methods to reduce the risk of spreading influenza.
b. Influenza Vaccine. Two influenza vaccines, Northern Hemisphere (NH)
and Southern Hemisphere (SH) are available based on service member location
and timing requirements as described in reference (b). The 2021-2022
Department of Defense (DoD) influenza season vaccine supply will be comprised
of injectable vaccines. Intranasal vaccine will not be provided through the
central ordering process.
c. Influenza Vaccine Priority. U.S. Navy ships, operational assets, and
training commands have been identified by the DoD and Department of Navy
(DON) as vaccine priority groups for the 2021-2022 influenza season.
d. Influenza Vaccine Ordering. The Vaccine Information and Logistics
System (VIALS) is the online requisition system for seasonal influenza
vaccine. VIALS tracks requisitioned vaccine electronically via Military
Standard Requisitioning and Issuing Procedure (MILSTRIP) from requisition to
receipt. Navy influenza vaccine is centrally funded. The VIALS Web site is
common access card enabled:
e. The Naval Medical Logistics Command (NAVMEDLOGCOM) is responsible for
ordering and distributing influenza vaccine for all Navy and Marine Corps
activities. Additional quantities required must be coordinated with the
NAVMEDLOGCOM Influenza Vaccine Manager, (240) 308-2779, DSN:
343-8054 or the Vaccine Information and Logistics System (VIALS) helpdesk
f. Influenza Vaccine Shipping. All ordering commands will verify their
correct shipping address and point of contact information in VIALS to ensure
g. Influenza Vaccine Integrity
(1) Temperature Monitors. All Influenza vaccine shipments include
temperature monitors. All monitors must be returned to the Defense Logistics
Agency Troop Support Medical (DLA-TSM) cold chain office after receipt per
the included instructions and shipping materials.
(a) No Alarm Status. The vaccine is ready for immediate use.
(b) Alarmed Status. Do not administer vaccine. Segregate the
vaccine in the refrigerator with a sign saying DO NOT USE, return temperature
monitor to DLA-TSM, and await disposition.
h. Influenza Vaccine Exercise. Previous influenza seasons have been
used to exercise and evaluate mass vaccination scenarios. These coordinated
mass vaccination campaigns provide rapid and efficient vaccinations to
protect the maximum number of susceptible persons. Process improvements are
made to delivery and reporting procedures based on lessons learned. Ensure
masking, social distancing, group size limitations, and other appropriate
precautions during any mass vaccination exercises, if undertaken.
i. Vaccine Delivery. Due to vaccine demand and manufacturer
limitations, complete vaccine delivery may not occur until mid-November.
This delay will unintentionally test the ability to conduct rapid and
complete mass vaccination exercises.
j. Influenza Vaccination Compliance
(1) Navy Military Personnel. The seasonal influenza vaccination is
mandatory for all DoD uniformed personnel who are not medically or
administratively exempt, per references (a), (b), and (d). Any refusal to
receive the influenza vaccine will constitute a failure to obey a lawful
order and may be punishable under the Uniform Code of Military Justice and/or
result in administrative action. Prior to receiving the influenza vaccine,
Navy Active and Reserve Component personnel will have access to healthcare
providers to address questions or concerns with influenza vaccination.
Commands must consult with the servicing Staff Judge Advocate General for
additional guidance on influenza vaccination non-compliance.
(2) Navy Civilian Personnel. Influenza vaccination is required for
all civilian healthcare personnel as per reference (b), and is strongly
encouraged for all other Navy civilian employees.
(3) TRICARE Beneficiaries. Reference (c) authorizes retail network
pharmacies to administer the seasonal influenza vaccine. TRICARE
beneficiaries may receive influenza vaccinations with no co-pay at authorized
retail network pharmacies. Beneficiaries are encouraged to contact the
pharmacy regarding age restrictions as some pharmacies do not administer the
influenza vaccine to individuals younger than 18 years of age.
k. Influenza Vaccination Reporting. Active and Reserve Component Navy
force vaccination administration compliance will be monitored via the Medical
Readiness Reporting System (MRRS). Designated command personnel will access
MRRS to track their personnel to ensure compliance.
(1) Shore-based commands will request access to MRRS based on their
unit identification code by submitting a system access authorization request
available at: //mrrs.dc3n.navy.mil/mrrs (note: MRRS Web address is case
sensitive). Point of contact: MRRS program office and e-mail:
email@example.com (800) 537-4617 / (504) 697-7070/DSN: 647-7070. Ship-
based commands may utilize Navy Medicine Online (NMO) or Shipboard Non-
Tactical Automated Data Processing (SNAP) Automated Medical System (SAMS) to
(2) Commands must ensure that documentation of influenza vaccine
administration is coded to accurately reflect the type of vaccine given.
(3) Afloat units will enter influenza immunizations into the
Shipboard Automated Medical System/Theater Medical Information Program
Maritime (TMIP-M) for subsequent transfer to MRRS.
(4) All personnel who receive the vaccination from a retail network
pharmacy must provide documentation of vaccination no later than the next
workday for Active Component or within 7 days for Reserve Component to ensure
compliance is appropriately recorded in their electronic health records and
(5) Vaccination Timeline
(a) Due to the risk of infection transmission within the unit and
impact on operations, it is imperative that the vaccine be given with minimal
delay as possible. Active duty units have 72 hours (three business working
days) following receipt of the vaccine to administer and document the
vaccine. The 72-hour requirement begins immediately only if the temperature
monitor is in no alarm status upon receipt; if in alarmed status the timed
requirement begins once/if the vaccine is cleared for use by DLA-TSM. If the
72 hour requirement cannot be met, unit situation reports will be submitted
to the respective Immediate Superior in Command and Type Commanders.
Situation reports are not required if the temperature monitor is in alarmed
status and the unit is awaiting disposition from DLA-TSM.
(b) As Reserve Component Command schedules vary, NAVMEDLOGCOM and
DLA-TSM will coordinate to make every effort for the vaccine to arrive the
week of a drill weekend. Units have 30 days following receipt of the vaccine
to document, administer, and report vaccination if the temperature monitor is
in a no alarm status. If in alarmed status, the timed requirement begins
once/if the vaccine is cleared for use by DLA-TSM.
(6) Per paragraph 2.i, uniformed member compliance must be tracked in
MRRS. If desired, installations and medical treatment facilities (MTF) may
also use the Navy Family Accountability and Assessment System (NFAAS) to
conduct a Pandemic Influenza response exercise in conjunction with the
seasonal influenza vaccine program.
l. U.S. Navy Goals and Performance Standards
(1) To ensure force medical readiness before peak influenza season,
all Navy operational units and Navy Medical Readiness and Training
(NMRTC/U) will administer the 2021-2022 influenza vaccination to exceed the
90 percent vaccination goal by 15 December 2021 for Active and Reserve
Complete vaccine access will be provided for all Navy family (includes
dependents, other beneficiaries, and DON civilians). Active coordination
between command leadership, public affairs officers, and medical personnel is
necessary to achieve success.
(2) Influenza Vaccination Performance Standards. The following goals
will be monitored:
(a) Navy VIALS reports 100 percent of shipped vaccine received
onboard by fleet and Navy units by 1 December 2021.
(b) MRRS reports 90 percent of Active and Reserve Component
vaccinated by 15 December 2021. Commands will coordinate with the servicing
MTF to align command-wide vaccinations with Navy vaccination goals. Medical
personnel at servicing MTFs will promptly report vaccinations in MRRS.
m. Vaccine administration and Coronavirus Disease 2019 (COVID-19)
(1) There is no current contraindication for administration of the
influenza vaccination during the COVID-19 pandemic and every effort should be
made to deliver the flu vaccine as quickly as possible to eligible Service
(2) If a SARS-CoV-2 vaccine is available during the seasonal
influenza vaccination period, commands will follow instructions from the CDC
and per reference (f).
3. Released by Mr. Andrew S. Haeuptle, Director, Navy Staff.// BT